CORDIS
EU research results

CORDIS

English EN

Advanced Teaching and TRaining for Adoptive Cell Therapy

Project information

Grant agreement ID: 238778

Status

Closed project

  • Start date

    1 October 2009

  • End date

    30 September 2013

Funded under:

FP7-PEOPLE

  • Overall budget:

    € 2 838 539,06

  • EU contribution

    € 2 838 539,06

Coordinated by:

THE UNIVERSITY OF MANCHESTER

United Kingdom

Objective

Considerable resources are devoted to fighting cancer throughout Europe, yet these efforts are not producing the results that health practitioners and citizens might expect. This is partly due to the fragmentation and duplication of research efforts within Member states and the lack of co-ordination at European level. However it can also be attributed to the need to retain and most importantly develop researchers within the EU who have the research skills required to make a real contribution to cancer treatment. The need for quality researchers is particularly acute within the emerging interdisciplinary field of Adoptive Cell Therapy. This promising advance in cancer treatment is based on the exploitation of tumour immunology and genetic technology and built on the specific ideas and techniques originally proposed by the European and Israeli scientists who are members of the ATTRACT network. To facilitate further development within the field of adoptive cell therapy, it is crucial that a co-ordinated and intersectoral approach (combining both the research community and industry) is taken, an approach that broadens the portfolio of skills currently retained within the EU research community. Through the integration Europe’s undisputed leaders in the field of adoptive cell therapy established in the 2005 FP6 ATTACK project, the ATTRACT network aims to foster the development of a pool of ESR’s and ER’s by equipping them with the multidisciplinary and complementary skills needed to not only initiate further advances in the field but to become future leaders within the field of adoptive cell therapy for cancer treatment. Such skills are global in demand making each researcher a highly desirable candidate for employment and very mobile across the different career domains.

Coordinator

THE UNIVERSITY OF MANCHESTER

Address

Oxford Road
M13 9pl Manchester

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 443 065,95

Administrative Contact

Liz Fay (Ms.)

Participants (14)

WEIZMANN INSTITUTE OF SCIENCE

Israel

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands

EU Contribution

€ 198 504,50

MOLECULAR MEDICINE SPA

Italy

EU Contribution

€ 202 350,01

STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS

Netherlands

EU Contribution

€ 198 504,50

MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)

Germany

EU Contribution

€ 198 949,29

KLINIKUM DER UNIVERSITAET ZU KOELN

Germany

EU Contribution

€ 409 417,78

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS

France

EU Contribution

€ 203 062,74

THE CHRISTIE NHS FOUNDATION TRUST

United Kingdom

EU Contribution

€ 190 529,49

UCL Elizabeth Garrett Anderson Institute for Women’s Health

United Kingdom

EU Contribution

€ 209 899,56

OSPEDALE SAN RAFFAELE SRL

Italy

EU Contribution

€ 202 273,08

HUMANITAS MIRASOLE SPA

Italy

EU Contribution

€ 202 273,08

MILTENYI BIOTEC GMBH

Germany

EU Contribution

€ 179 709,08

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR

Italy

FONDAZIONE CENTRO SAN RAFFAELE

Italy

Project information

Grant agreement ID: 238778

Status

Closed project

  • Start date

    1 October 2009

  • End date

    30 September 2013

Funded under:

FP7-PEOPLE

  • Overall budget:

    € 2 838 539,06

  • EU contribution

    € 2 838 539,06

Coordinated by:

THE UNIVERSITY OF MANCHESTER

United Kingdom